3jc48-3

N/A

Report date: 2022/07/28 10:47:35
NME

Base Information

Drug Name3jc48-3
Drug Alias Name3-jc-48-33jc48-3
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Myc/Max complex inhibitors
Targetsc-Myc/Max complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland, Baltimore
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A